Advertisement

Topics

Cuba to access rituximab biosimilar through Biocad

13:05 EDT 17 May 2018 | thePharmaLetter

Russian biosimilar manufacturer Biocad has had its rituximab equivalent approved by the Cuban Ministry…

Original Article: Cuba to access rituximab biosimilar through Biocad

NEXT ARTICLE

More From BioPortfolio on "Cuba to access rituximab biosimilar through Biocad"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...